| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Latigo Biotherapeutics, Inc. (LTGO) have been net buyers, picking up 140,000 shares worth roughly $2.5M on balance. In the past 30 days, 1 insider bought and 0 sold. The tilt toward buying has held up recently.
Foresite Capital Management V, LLC (10% Owner) stands out among recent buyers.
LTGO sits in the Biotechnology industry within the Healthcare sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.12M | $58.58M | +140.0K | |
| Dir | 105.5K | $1.98M | - | |
| 10% | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | Foresite Capital Management V, LLC | 10% Owner | Buy | 140,000 | $18.00 | $2,520,000.00 | +7.5% |